CoreLine Soft Co

CoreLine Soft Co SGA/Revenue

The SGA to Revenue Ratio of CoreLine Soft Co (384470.KQ) as of Nov 11, 2026 is 133.23 %. In the previous year, SGA to Revenue Ratio was 341.20 % — a change of -60.95% (lower).

SGA/Revenue

133.23 %

YoY

-60.95%

Last updated:

SGA to Revenue Ratio of CoreLine Soft Co is 2025 133.23 % . SGA to Revenue Ratio of CoreLine Soft Co was 2024 341.20 % . It decreases by -60.95% lower compared to the previous year.

The CoreLine Soft Co SGA/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

SGA/Revenue
Date
SGA/Revenue
Jan 1, 2020
183.13 KRW
Jan 1, 2021
163.69 KRW
Jan 1, 2022
255.03 KRW
Jan 1, 2023
295.16 KRW
Jan 1, 2024
341.20 KRW
Jan 1, 2025
133.23 KRW
The CoreLine Soft Co SGA/Revenue history
YEARSGA/RevenueYoY
133.23 %-60.95%
341.20 %+15.60%
295.16 %+15.74%
255.03 %+55.80%
163.69 %-10.62%
183.13 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CoreLine Soft Co Stock analysis

What does CoreLine Soft Co do? CoreLine Soft Co Ltd develops and supplies AI-based medical image analysis software for healthcare professionals. The company's main products analyze CT images of the chest, head, and neck to assist in diagnosis and support treatment and research. The firm targets medical staff in hospitals and research institutions who require advanced diagnostic tools. CoreLine Soft generates revenue through the sale of its medical software solutions to healthcare providers and research organizations. The company operates in the Health Care Technology industry with a focus on AI-driven medical imaging. CoreLine Soft's products are designed to enhance diagnostic accuracy and streamline treatment planning for medical professionals. Revenue is derived from licensing agreements with healthcare facilities and research entities that integrate the software into their diagnostic workflows. CoreLine Soft Co Ltd is a Korea-based company headquartered in Seoul. The firm's primary business model revolves around the development and commercialization of AI-based medical software. The company's revenue streams come from direct sales of its CT image analysis solutions to hospitals and research institutions seeking to improve diagnostic efficiency and patient outcomes. CoreLine Soft Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CoreLine Soft Co stock

SGA to Revenue Ratio of CoreLine Soft Co is 133.23 % in 2025.

SGA to Revenue Ratio of CoreLine Soft Co changed from 341.20 % to 133.23 %, representing a -60.95% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of SGA to Revenue Ratio CoreLine Soft Co since 2006 – with annual values, charts, and detailed analysis.

The SGA/Revenue ratio shows what percentage of revenue is consumed by selling, general, and administrative costs. Lower ratios indicate greater operating efficiency.

A 'good' varies by industry and company stage. On Eulerpool, you can compare SGA to Revenue Ratio's CoreLine Soft Co with sector peers and the industry average to assess whether it is attractive.

To evaluate SGA to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for SGA to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — CoreLine Soft Co

All Key Metrics — CoreLine Soft Co